Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
BPC-157 may not fit research involving: Purely structural muscle wasting (where cell migration is the primary bottleneck, not blood flow) Models where rapid angiogenesis is contraindicated (e.g., certain tumor models) TB-500 may not fit research involving: Gastrointestinal rescue or leaky gut models (it has no known direct affinity for GI tissue repair) Tendon-to-bone insertions (BPC-157 shows superior efficacy here due to its effect on bone collagen) Common Mistakes Mistake: Expecting either peptide to act like an anabolic steroid
DSIP , ,
What is BPC 157, and how does it work in the body
One large placebo-controlled trial (presented at the AUA meeting in 2007) tested intranasal bremelanotide in 726 men with ED (average age 55) over 12 weeks
US$ 24.82
US$ 22.88
US$ 29.05
US$ 29.08
US$ 22.04
US$ 20.10